Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 767K 880K 711K 665K 1.25M 83.04M 1.26M 8.43M 3.27M 40.88M 3.3M 3.23M 142M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.46M 10.87M 10.17M 19.08M 1.27B 19.2M 129M 49.97M 625M 50.52M 49.44M 2.17B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.56% | +13.31% | +99.96% | +105.56% | 4.28B | |
| +4.47% | -0.40% | +67.43% | +108.94% | 2.81B | |
| +3.92% | +3.83% | -25.97% | -38.60% | 2.01B | |
| -0.51% | -4.17% | +91.67% | -51.85% | 1.75B | |
| +11.50% | +13.97% | +37.57% | +228.89% | 1.35B | |
| -3.47% | -0.89% | -17.75% | +17.55% | 837M | |
| -0.38% | +4.42% | +158.71% | -62.26% | 767M | |
| -10.32% | -23.08% | +54.07% | - | 596M | |
| -1.73% | -5.87% | -30.10% | -17.39% | 508M | |
| Average | +0.89% | -0.83% | +48.40% | +36.35% | 1.66B | |
| Weighted average by Cap. | +2.98% | +2.78% | +60.33% | +59.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.53K 22.23K 20.81K 39.02K 2.6M 39.26K 264K 102K 1.28M 103K 101K 4.44M |
| Net income | -3.35M -3.84M -3.1M -2.91M -5.45M -363M -5.48M -36.83M -14.27M -179M -14.43M -14.12M -620M | -314K -360K -291K -272K -511K -33.98M -514K -3.45M -1.34M -16.73M -1.35M -1.32M -58.08M |
| Net Debt | 10.46M 11.99M 9.68M 9.06M 17M 1.13B 17.1M 115M 44.52M 557M 45.01M 44.05M 1.93B | 10.97M 12.58M 10.16M 9.51M 17.83M 1.19B 17.94M 120M 46.7M 584M 47.22M 46.2M 2.03B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
